MURINE T LYMPHOCYTE SUBSETS AND ALLOGRAFT REJECTION
MURINE T LYMPHOCYTE SUBSETS AND ALLOGRAFT REJECTION
批准号:
6099466
负责人:
FRANK W. FITCH
金额:
$14.48万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-09-01 至 2000-08-31
关键词:
B lymphocyte CD8 molecule MHC class I antigen T lymphocyte antigen presenting cell cell cycle proteins cell population study cellular immunity clone cells cytokine genetically modified animals homologous transplantation laboratory mouse neutralizing antibody pore forming protein protein biosynthesis skin transplantation spleen transplantation surface antigens tissue /cell culture transplant rejection
中文摘要
T细胞、B细胞和抗原呈递细胞之间的相互作用启动
由细胞因子和细胞因子介导和调节的免疫应答
表面相互作用CD 4 + T细胞的亚群已经在
分泌性淋巴因子的基础。CD 8 + T细胞的亚群尚未被发现。
详细描述。提出的研究总体目标
项目2是确定管理国家机构职能的机制的特点,
T淋巴细胞负责同种异体移植物的排斥反应,
重点是CD 8 + T细胞。我们将定义CD 8 + T细胞亚群
与单个主要组织相容性复合体(MHC)抗原反应,
以及确定控制这些T细胞反应的机制,
细胞亚群我们将主要研究对I类MHC抗原的反应,
尤其是H-2Ld。为实现这一目标,提出了三个具体目标
总体目标:1)确定细胞因子和细胞表面分子
参与激活幼稚和致敏的CD 8 + T细胞反应,
用H-2Ld I类MHC抗原,使用来自转基因小鼠的T细胞,
CD 8 + T细胞表达抗原特异性的转基因(Tg)α/β T
细胞受体(TCR),其与H-2Ld同种异体抗原反应。初始cd 8 + T
细胞将从未致敏的脾脏和淋巴结中获得。敏化
CD 8 + T细胞将从引流淋巴结的部位获得。
腹腔内移植后排斥同种异体皮肤或脾脏
注射同种异体细胞。特定淋巴因子的作用(包括
IL-1、IL-2、IL-4、IL-10和IL-12)和细胞表面分子(包括
B7-1、B7-2、CD 28、CTLA-4、LFA-1、ICAM-1)活化增殖,
淋巴因子的产生和细胞溶解活性的获得将是
使用中和单克隆抗体(mAb)和各种
抗原呈递细胞(APC)群体; 2)衍生克隆
代表各种CD 8 + T细胞亚群,并比较
这些克隆与那些控制幼稚的克隆一起调节各种功能,
CD 8 + T细胞。为实现具体目标1而提出的实验应
确定必要条件(淋巴因子和细胞表面分子)
刺激CD 8 + Tg T细胞产生那些淋巴因子,
CD 4 + T辅助细胞(Th)的不同亚群,即白细胞介素(IL)
IL-2和干扰素-γ(IFN-γ)对Th 1和IL-4、IL-5、IL-6和IL-10的影响
对于Th 2。利用这些信息,我们将定义导致
选择性地激活一个或另一个子集,我们将得出
分泌不同淋巴因子阵列的CD 8 + Tg T细胞的克隆。我们
将确定代表CD 8+亚群的克隆的功能,测量
产生淋巴因子、提供B细胞帮助和细胞溶解活性
由穿孔素和Fas介导。我们还将评估各种能力,
调节初始CD 4+和CD 8 + T细胞以及CD 4 + T细胞的应答的CD 8+亚群
和CD 8+克隆;以及3)基于通过以下获得的信息:
其他具体目标,开发抑制同种异体移植物的策略
排斥反应可能的疗法包括使用与以下物质反应的mAb:
特定的细胞因子和/或mAb或其它与细胞反应的试剂
特定T细胞亚群或APC上的表面结构。
英文摘要
Interactions among T cells, B cells, and antigen-presenting cells initiate
immune responses which are mediated and regulated by cytokines and by cell
surface interactions. Subsets of CD4+ T cells have been identified on the
basis of secreted lymphokines. Subsets of CD8+ T cells have not been
characterized in detail. The general goal of the research proposed in
Project 2 is to characterize the mechanisms that regulate the functions of
T lymphocytes which are responsible for rejection of allografts, with
emphasis placed on CD8+ T cells. We will define CD8+ T cell subsets
reacting to individual major histocompatibility complex (MHC) antigens as
well as determining the mechanisms that control the responses of these T
cell subsets. We will study mainly the response to class I MHC antigens,
particularly H-2Ld. Three Specific Aims are proposed to accomplish this
general goal: 1) To determine the cytokines and cell surface molecules
that are involved in activating naive and primed CD8+ T cells reactive
with H-2Ld class l MHC antigen, using T cells from transgenic mice whose
CD8+ T cells express an antigen-specific, transgenic (Tg), alpha/beta T
cell receptor (TCR) which reacts with H-2Ld alloantigen. Naive CD8+ T
cells will be obtained from unprimed spleen and lymph nodes. Sensitized
CD8+ T cells will be obtained from lymph nodes draining the site of a
rejecting skin allograft or from the spleen following intraperitoneal
injection of allogeneic cells. The role of specific lymphokines (including
IL-1, IL-2, lL-4, lL-1O and lL-12) and cell surface molecules (including
B7-1, B7-2, CD28, CTLA-4, LFA-1, ICAM-1) in activation for proliferation,
lymphokine production, and acquisition of cytolytic activity will be
determined, using neutralizing monoclonal antibodies (mAb) and various
populations of antigen-presenting cells (APC); 2) To derive clones
representing various CD8+ T cell subsets and compare the mechanisms that
regulate various functions of these clones with those controlling naive
CD8+ T cells. The experiments proposed to accomplish Specific Aim 1 should
define the essential conditions (lymphokines and cell surface molecules)
for stimulating CD8+ Tg T cells to produce those lymphokines that have
distinguished subsets of CD4+ T helper (Th) cells, namely interleukin (IL)
2 and interferon-gamma (IFN-gamma) for Th1 and IL-4, lL-5, lL-6, and lL-10
for Th2. Using this information, we will define conditions that lead
selectively to activation of one or another subset, and we will derive
clones of CD8+ Tg T cells that secrete different lymphokines arrays. We
will determine functions of clones representing CD8+ subsets, measuring
lymphokine production, provision of B cell help, and cytolytic activity
mediated by perforin and Fas. We also will evaluate the ability of various
CD8+ subsets to regulate responses of naive CD4+ and CD8+ T cells and CD4+
and CD8+ clones in vitro; and 3) Based on the information obtained through
the other Specific Aims, to develop strategies for suppressing allograft
rejection. Possible therapies include the use of mAb reactive with
particular cytokines and/or mAb or other reagents that react with cell
surface structures on the particular T cell subsets or APC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANERGY AND SIGNALING IN MURINE T CELL SUBSETS
-
批准号:6352593
-
项目类别:
-
资助金额:$17.7万
-
财政年份:2000
-
负责人:FRANK W. FITCH
-
依托单位:
ANERGY AND SIGNALING IN MURINE T CELL SUBSETS
-
批准号:6201184
-
项目类别:
-
资助金额:$17.7万
-
财政年份:1999
-
负责人:FRANK W. FITCH
-
依托单位:
ANERGY AND SIGNALING IN MURINE T CELL SUBSETS
-
批准号:6099749
-
项目类别:
-
资助金额:$17.7万
-
财政年份:1998
-
负责人:FRANK W. FITCH
-
依托单位:
CORE--ANALYTICAL REAGENTS FACILITY
-
批准号:6099471
-
项目类别:
-
资助金额:$14.48万
-
财政年份:1998
-
负责人:FRANK W. FITCH
-
依托单位:
CORE--ANALYTICAL REAGENTS FACILITY
-
批准号:6234971
-
项目类别:
-
资助金额:$10.03万
-
财政年份:1997
-
负责人:FRANK W. FITCH
-
依托单位:
MURINE T LYMPHOCYTE SUBSETS AND ALLOGRAFT REJECTION
-
批准号:6234966
-
项目类别:
-
资助金额:$10.03万
-
财政年份:1997
-
负责人:FRANK W. FITCH
-
依托单位:
ANERGY AND SIGNALING IN MURINE T CELL SUBSETS
-
批准号:6235195
-
项目类别:
-
资助金额:$17.05万
-
财政年份:1997
-
负责人:FRANK W. FITCH
-
依托单位:
REGULATION OF T LYMPHOCYTE IMMUNE RESPONSES
-
批准号:3479593
-
项目类别:
-
资助金额:$60.07万
-
财政年份:1987
-
负责人:FRANK W. FITCH
-
依托单位:
REGULATION OF T LYMPHOCYTE IMMUNE RESPONSES
-
批准号:3479596
-
项目类别:
-
资助金额:$68.43万
-
财政年份:1987
-
负责人:FRANK W. FITCH
-
依托单位:
REGULATION OF T LYMPHOCYTE IMMUNE RESPONSES
-
批准号:3479591
-
项目类别:
-
资助金额:$41.9万
-
财政年份:1987
-
负责人:FRANK W. FITCH
-
依托单位:
REGULATION OF T LYMPHOCYTE IMMUNE RESPONSES
-
批准号:3479594
-
项目类别:
-
资助金额:$69.86万
-
财政年份:1987
-
负责人:FRANK W. FITCH
-
依托单位:
REGULATION OF T LYMPHOCYTE IMMUNE RESPONSES
-
批准号:3479595
-
项目类别:
-
资助金额:$71.89万
-
财政年份:1987
-
负责人:FRANK W. FITCH
-
依托单位:
REGULATION OF T LYMPHOCYTE IMMUNE RESPONSES
-
批准号:3479592
-
项目类别:
-
资助金额:$58.56万
-
财政年份:1987
-
负责人:FRANK W. FITCH
-
依托单位:
REGULATION OF T LYMPHOCYTE IMMUNE RESPONSES
-
批准号:2091459
-
项目类别:
-
资助金额:$73.12万
-
财政年份:1987
-
负责人:FRANK W. FITCH
-
依托单位:
MOLECULAR BASIS FOR T LYMPHOCYTE FACTOR ACTIVITY
-
批准号:3127649
-
项目类别:
-
资助金额:$13.53万
-
财政年份:1982
-
负责人:FRANK W. FITCH
-
依托单位:
MOLECULAR BASIS FOR T LYMPHOCYTE FACTOR ACTIVITY
-
批准号:3127651
-
项目类别:
-
资助金额:$8.97万
-
财政年份:1982
-
负责人:FRANK W. FITCH
-
依托单位:
MOLECULAR BASIS FOR T LYMPHOCYTE FACTOR ACTIVITY
-
批准号:3127652
-
项目类别:
-
资助金额:$10.2万
-
财政年份:1982
-
负责人:FRANK W. FITCH
-
依托单位:
MOLECULAR BASIS FOR T LYMPHOCYTE FACTOR ACTIVITY
-
批准号:3127648
-
项目类别:
-
资助金额:$13.12万
-
财政年份:1982
-
负责人:FRANK W. FITCH
-
依托单位:
MOLECULAR BASIS FOR T LYMPHOCYTE FACTOR ACTIVITY
-
批准号:3127650
-
项目类别:
-
资助金额:$10.63万
-
财政年份:1982
-
负责人:FRANK W. FITCH
-
依托单位:
ANTIBODY FORMATION BY LYMPHOID CELLS
-
批准号:3124185
-
项目类别:
-
资助金额:$16.89万
-
财政年份:1978
-
负责人:FRANK W. FITCH
-
依托单位:
海外基金